News in Gastric Cancer

News from around the world, curated by the Gastric Cancer Foundation.
research cancer

Apatinib Shows Promising Survival Advantage in Advanced Gastric Cancer

Apatinib demonstrated an improvement in overall survival (OS) by 1.8 months and an acceptable toxicity profile compared to placebo as treatment for advanced gastric cancer, according to findings published in the Journal of Clinical Oncology.

Read Source
X